Definium Therapeutics Inc.
DFTX | NASDAQ
$33.82
-$2.51 (-6.91%)
Nov 2, 2026, 12:32 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -353.79M | -237.54M | -183.79M | -168.1M | -114.52M | -77.63M | -108.68M | -97.8M | -102.04M | -125.32M | -95.73M | -76.77M | -75.33M | -63.16M | -56.8M | -70.64M | -71.35M | -99.65M | -94.95M | -88.73M | -80.17M | -40.67M |
Depreciation & Amortization | n/a | 631K | n/a | n/a | n/a | n/a | 527K | 1.32M | 2.11M | 2.9M | 3.16M | 3.16M | 3.16M | 3.19M | 3.18M | -2.7M | -2.7M | -2.74M | -3.26M | 1.42M | 764.5K | 122.5K |
Stock-Based Compensation | 34M | 29.62M | 25.91M | 17.94M | 15.89M | 16.07M | 16.33M | 16.57M | 17.02M | 15.43M | 15.49M | 13.19M | 13.25M | 13.67M | 13.71M | 23.37M | 23.19M | 51.93M | 49.41M | 43.49M | 43.4M | 8.27M |
Other Working Capital | 12.69M | 12.38M | 6M | 7.54M | 7.97M | 1.34M | 1.87M | 1.67M | -3.17M | 535K | 4.26M | 1.14M | 1.84M | -2.05M | -1.73M | -777K | -6.44M | -3.82M | -5.08M | -399.38K | 5.9M | 2.83M |
Other Non-Cash Items | 137.56M | 46.45M | 18.16M | 22.72M | -12.44M | -28.36M | 12.94M | 9.4M | 18.2M | 34.33M | 5.26M | -5.35M | -1.25M | -1.25M | -6.45M | 2.76M | 1.25M | 1.23M | 1.23M | -1.54M | -4M | -667.27K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.17M | 1.17M | 1.17M | 1.17M | n/a | n/a | -1.16M | -1.16M | -1.16M | -1.16M | n/a | n/a | n/a |
Change in Working Capital | 15.35M | 17.16M | 9.25M | 13.5M | 9.5M | -2.04M | -254.21K | -3.83M | -9.06M | 3.86M | 6.28M | 7.94M | 9.68M | -3.05M | -3.78M | -2.82M | -7.9M | -4.33M | -3.16M | 234.63K | 5.85M | 4.41M |
Operating Cash Flow | -166.87M | -143.69M | -130.48M | -113.94M | -101.56M | -91.95M | -79.13M | -74.34M | -73.78M | -67.63M | -64.37M | -56.65M | -49.32M | -50.6M | -50.14M | -51.19M | -58.68M | -54.72M | -51.89M | -45.13M | -34.15M | -28.53M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | 47K | 47K | 45K | -2K | -2K | -2K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 178K | 178K | 178K | -119K | -297K | -297K | -297K |
Purchase of Investments | -384.88M | -102.43M | -264.89M | -262.34M | -235.75M | -162.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 163.08M | 124.08M | 82.08M | 42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 33.75M | 33.75M | 33.75M | 33.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -27K | -94K | -111K | -111K | -84K | -17K |
Investing Cash Flow | -221.8M | 55.4M | -149.06M | -186.59M | -202M | -162.46M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 225K | 198K | 131K | -185K | -410K | -383K | -316K |
Debt Repayment | 187.81K | 20.1M | 20.1M | 21.34M | 20.89M | 10.79M | 10.66M | 9.63M | 23.83M | 14.03M | 14.16M | 14.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -407K | -407K | -407K | -407K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -46.3M | -316.18K | 499.82K | 3.79M | -1.4M | 380.45K | -7.04M | -10.8M | -5.04M | -6.45M | 163K | -200K | 16.33M | 16.92M | 17.16M | 17.6M | 1.78M | 9.27M | 9.03M | 33.61M | 32.79M | 24.72M |
Financial Cash Flow | 1.01B | 272.33M | 268.02M | 25.21M | 93.81M | 84.95M | 253.2M | 251.98M | 200.03M | 190.51M | 21.85M | 19.67M | 60.48M | 59.8M | 59.05M | 58.76M | 1.37M | 8.67M | 98.83M | 167.41M | 166.56M | 167.79M |
Net Cash Flow | 621.88M | 179.66M | -15.9M | -275.33M | -209.74M | -169.48M | 174.04M | 177.59M | 126.24M | 122.92M | -42.44M | -36.82M | 11.15M | 8.94M | 8.6M | 8.6M | -51.36M | -39.57M | 53.39M | 127.63M | 132.98M | 139.48M |
Free Cash Flow | -166.87M | -143.69M | -130.48M | -113.94M | -101.56M | -91.95M | -79.13M | -74.34M | -73.78M | -67.63M | -64.37M | -56.65M | -49.32M | -50.6M | -50.14M | -51.14M | -58.63M | -54.67M | -51.84M | -45.13M | -34.15M | -28.53M |
Adj. Free Cash Flow | -200.87M | -173.31M | -156.39M | -131.88M | -117.45M | -108.02M | -95.46M | -90.91M | -90.8M | -83.07M | -79.86M | -69.85M | -62.58M | -64.27M | -63.85M | -74.51M | -81.82M | -106.6M | -101.26M | -88.62M | -77.56M | -36.8M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -47K | -47K | -47K | -49K | -2K | -2K | -2K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 94K | 94K | 94K | 94K | n/a | n/a | n/a |
Owner Earnings | -166.87M | -143.69M | -130.48M | -113.94M | -101.56M | -91.95M | -79.13M | -74.34M | -73.78M | -67.63M | -64.37M | -56.65M | -49.32M | -50.6M | -50.14M | -51.24M | -58.72M | -54.77M | -51.94M | -45.13M | -34.16M | -28.54M |
Add to Watchlist
Select watchlists to add or remove DFTX